Search

Your search keyword '"Politiques publiques, ACtion politique, TErritoires (PACTE) ' showing total 3 results
Start Over Author "Politiques publiques, ACtion politique, TErritoires (PACTE) Language english
3 results on '"Politiques publiques, ACtion politique, TErritoires (PACTE) '

1. Volatile and semi-volatile organic compounds of respiratory health relevance in French dwellings

Author

A. Dallongeville, Séverine Deguen, Isabella Annesi-Maesano, B. Le Bot, Olivier Blanchard, Nathalie Costet, Denis Zmirou-Navier, Cécile Chevrier, Institut de recherche en santé, environnement et travail (Irset), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), École des Hautes Études en Santé Publique [EHESP] (EHESP), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), French Environment and Energy Management Agency (ADEME), French Agency for Food, Environmental and Occupational Health & Safety (Anses), Dynamique de l'information génétique : bases fondamentales et cancer (DIG CANCER), Université Pierre et Marie Curie - Paris 6 (UPMC) - INSTITUT CURIE - Centre National de la Recherche Scientifique (CNRS), Institut de recherche, santé, environnement et travail [Rennes] (Irset), Université d'Angers (UA) - Université des Antilles et de la Guyane (UAG) - Université de Rennes 1 (UR1) - École des Hautes Études en Santé Publique [EHESP] (EHESP) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), École nationale supérieure d'architecture de Nantes (ENSA Nantes), équipe EDDEN, Politiques publiques, ACtion politique, TErritoires (PACTE), Université Pierre Mendès France - Grenoble 2 (UPMF) - Université Joseph Fourier - Grenoble 1 (UJF) - Sciences Po Grenoble - Institut d'études politiques de Grenoble (IEPG) - Centre National de la Recherche Scientifique (CNRS) - Université Grenoble Alpes (UGA) - Université Pierre Mendès France - Grenoble 2 (UPMF) - Université Joseph Fourier - Grenoble 1 (UJF) - Sciences Po Grenoble - Institut d'études politiques de Grenoble (IEPG) - Centre National de la Recherche Scientifique (CNRS) - Université Grenoble Alpes (UGA), Toxicologie Moleculaire, Université Paris Descartes - Paris 5 (UPD5) - Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Département Santé Environnement Travail et Génie Sanitaire (DSETGS), Laboratoire d'étude et de recherche en environnement et santé (LERES), and Département Méthodes quantitatives en santé publique (METIS)

Subjects
Synthetic musks, Environmental Engineering, [SDV]Life Sciences [q-bio], Phthalic Acids, Indoor exposure, 010501 environmental sciences, Diethyl phthalate, 01 natural sciences, Fatty Acids, Monounsaturated, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Phthalates, Environmental health, Formaldehyde, Humans, 030212 general & internal medicine, Galaxolide, Volatile organic compounds, Child, Respiratory health, 0105 earth and related environmental sciences, Indoor air pollutants, Pollutant, Air Pollutants, Aldehydes, Principal Component Analysis, High prevalence, Chemistry, Public Health, Environmental and Occupational Health, Building and Construction, Environmental exposure, Diisobutyl phthalate, Environmental Exposure, [SDE.ES]Environmental Sciences/Environmental and Society, Asthma, 3. Good health, [SDV] Life Sciences [q-bio], 13. Climate action, Environmental chemistry, Air Pollution, Indoor, [SDE]Environmental Sciences, Housing, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Enviromnemt, France, Environmental Monitoring, Trihalomethanes
Abstract

International audience; Over the last decades, the prevalence of childhood respiratory conditions has dramatically increased worldwide. Considering the time spent in enclosed spaces, indoor air pollutants are of major interest to explain part of this increase. This study aimed to measure the concentrations of pollutants known or suspected to affect respiratory health that are present in dwellings in order to assess children's exposure. Measurements were taken in 150 homes with at least one child, in Brittany (western France), to assess the concentrations of 18 volatile organic compounds (among which four aldehydes and four trihalomethanes) and nine semi-volatile organic compounds (seven phthalates and two synthetic musks). In addition to descriptive statistics, a principal component analysis (PCA) was used to investigate grouping of contaminants. Formaldehyde was highly present and above 30 μg/m(3) in 40% of the homes. Diethyl phthalate, diisobutyl phthalate, and dimethylphthalate were quantified in all dwellings, as well as Galaxolide and Tonalide. For each chemical family, the groups appearing in the PCA could be interpreted in term of sources. The high prevalence and the levels of these compounds, with known or suspected respiratory toxicity, should question regulatory agencies to trigger prevention and mitigation actions.

Published
2016
Full Text
View/download PDF

2. Producing 'Human Elements Based Medical Technologies' in Biotech Companies: Some Ethical and Organisational Ingredients for Innovative Cooking

Author

Virginie Tournay, Aurélie Mahalatchimy, Anne Cambon-Thomsen, Séverine Louvel, Doerte Bemme, Céline Granjou, Emmanuelle Rial-Sebbag, Centre de Recherches Politiques de Sciences Po (CEVIPOF), Sciences Po - Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Montréal, Politiques publiques, ACtion politique, TErritoires (PACTE), Université Pierre Mendès France - Grenoble 2 (UPMF) - Université Joseph Fourier - Grenoble 1 (UJF) - Sciences Po Grenoble - Institut d'études politiques de Grenoble (IEPG) - Centre National de la Recherche Scientifique (CNRS) - Université Grenoble Alpes (UGA), CEMAGREF, Sciences Po Institutional Repository, Spire, Centre de recherches politiques de Sciences Po (Sciences Po, CNRS) (CEVIPOF), Sciences Po (Sciences Po)-Centre National de la Recherche Scientifique (CNRS), Université de Montréal (UdeM), Pacte, Laboratoire de sciences sociales (PACTE), Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Joseph Fourier - Grenoble 1 (UJF)-Sciences Po Grenoble - Institut d'études politiques de Grenoble (IEPG)-Centre National de la Recherche Scientifique (CNRS), Centre national du machinisme agricole, du génie rural, des eaux et forêts (CEMAGREF), and Centre de recherches politiques de Sciences Po (CEVIPOF)

Subjects
[SHS.ECO] Humanities and Social Sciences/Economies and finances, 050402 sociology, Process (engineering), Emerging technologies, Science, Judgement, 050905 science studies, 0504 sociology, Sociology, Emerging markets, [SHS.ECO] Humanities and Social Sciences/Economics and Finance, Multidisciplinary, business.industry, 05 social sciences, Biotech companies, Bioethics, [SHS.ECO]Humanities and Social Sciences/Economics and Finance, Biobank, [SHS.SCIPO]Humanities and Social Sciences/Political science, Biotechnology, Biobanks, Work (electrical), Science Studies, Engineering ethics, 0509 other social sciences, business, [SHS.SCIPO] Humanities and Social Sciences/Political science, Qualitative research
Abstract

This article is based on the findings of an EU-funded qualitative research project, entitled ‘From GMP to GBP: Fostering good bioethics practices [GBP] among the European biotechnology industry’, which seeks to improve the understanding of bioethical issues through the observation of the daily practices in European biotechnology companies and proposes a methodology approaching ethical issues. The comparative study was carried out in biotech companies in France, Italy, Sweden, Hungary and Belgium which develop a wide range of new technologies, all of them involving human materials or where human subjects participate (in clinical trials). Based on our findings in these local settings, we suggest that the notion of bioethics and the way its production is theorised need to be re-conceptualised. We argue that material practices and moral statements are intermingled in inextricable ways that render the formation of bioethical concerns fully dependent on the organisational landscape in which it is embedded. More precisely, the here presented co-production model of moral statements and organisational practices presents a set of common factors that influence how bioethical discourses are shaped, despite the heterogeneity of their epistemic cultures. For example, the procedural design of cell-based-products, the modes of collecting and storing biological specimen, the relationship between patients and companies and technological transfers to emerging countries are defining components that contribute to the shaping process of bioethical concerns. Thus, the path dependency of bioethical concerns relies on an already existing, specific infrastructure and existing relationships within and outside a company rather than on external judgement subsequently applied to its objects, or a collection of processes of reasoning coming from external institutions.

Published
2013
Full Text
View/download PDF

3. The Legal Landscape for Advanced Therapies: Material and Institutional Implementation of European Union Rules in France and the United Kingdom

Author

Virginie Tournay, Aurélie Mahalatchimy, Emmanuelle Rial-Sebbag, Alex Faulkner, Pacte, Laboratoire de sciences sociales (PACTE), Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Joseph Fourier - Grenoble 1 (UJF)-Sciences Po Grenoble - Institut d'études politiques de Grenoble (IEPG)-Centre National de la Recherche Scientifique (CNRS), Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherches politiques de Sciences Po (CEVIPOF), Sciences Po (Sciences Po)-Centre National de la Recherche Scientifique (CNRS), King‘s College London, Centre de recherches politiques de Sciences Po (Sciences Po, CNRS) (CEVIPOF), Sciences Po Institutional Repository, Spire, Politiques publiques, ACtion politique, TErritoires (PACTE), Université Pierre Mendès France - Grenoble 2 (UPMF) - Université Joseph Fourier - Grenoble 1 (UJF) - Sciences Po Grenoble - Institut d'études politiques de Grenoble (IEPG) - Centre National de la Recherche Scientifique (CNRS) - Université Grenoble Alpes (UGA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherches Politiques de Sciences Po (CEVIPOF), and Sciences Po - Centre National de la Recherche Scientifique (CNRS)

Subjects
Sociology and Political Science, [SHS.DROIT] Humanities and Social Sciences/Law, [SHS.SOCIO] Humanities and Social Sciences/Sociology, Advanced therapies, 030204 cardiovascular system & hematology, Public administration, History, 21st Century, 03 medical and health sciences, 0302 clinical medicine, [SHS.DROIT]Humanities and Social Sciences/Law, Political science, media_common.cataloged_instance, European Union, European union, health care economics and organizations, 030304 developmental biology, media_common, 0303 health sciences, Jurisprudence, Scope (project management), [SDV.ETH] Life Sciences [q-bio]/Ethics, United Kingdom, humanities, 3. Good health, [SDV.ETH]Life Sciences [q-bio]/Ethics, Regulatory bodies, Prescriptions, Work (electrical), Medical product, Regenerative medicine, Government Regulation, France, [SHS.SCIPO] Humanities and Social Sciences/Political science, Law, Institutional implementation
Abstract

In 2007, the European Union adopted a lex specialis, Regulation (EC) No. 1394/2007 on advanced therapy medicinal products (ATMPs), a new legal category of medical product in regenerative medicine. The regulation applies to ATMPs prepared industrially or manufactured by a method involving an industrial process. It also provides a hospital exemption, which means that medicinal products not regulated by EU law do not benefit from a harmonized regime across the European Union but have to respect national laws. This article describes the recent EU laws, and contrasts two national regimes, asking how France and the United Kingdom regulate ATMPs which do and do not fall under the scope of Regulation (EC) No. 1394/2007. What are the different legal categories and their enforceable regimes, and how does the evolution of these highly complex regimes interact with the material world of regenerative medicine and the regulatory bodies and socioeconomic actors participating in it?

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results